Insider · CIK 0001602773
Dan Puckett
Files at PRCT (PROCEPT BioRobotics Corp), SWAV (Shockwave Medical, Inc.). First filing Dec 11, 2023, latest Dec 11, 2023.
In brief
Dan Puckett files SEC Form 4 as director and CFO at SWAV (Shockwave Medical, Inc.), and also at PRCT (PROCEPT BioRobotics Corp). Since Dec 11, 2023, Dan Puckett has reported 0 open-market buys worth $0 and 1 open-market sell worth $35k, the latest filed on Dec 11, 2023.
A track record needs three past buys with six months of prices behind them; Dan Puckett has 0, so none is measured yet.
The newest scored trade: sold $35k of SWAV on Dec 8, 2023, filed Dec 11, 2023, scored 23 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Shockwave Medical, Inc. | $35k 200 shares | -1% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 8, 2023 | SHOCKWAVE MED INC | 200 0.00% of outstanding | $35k | Dec 8, 2023 | none |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | PRCT PROCEPT BioRobotics Corp | AGrant or award Common Stock | +3,315 | $0.00 | $0 | 8,791 | Jun 10, 2026 |
| Jun 9, 2026 | PRCT PROCEPT BioRobotics Corp | AGrant or award Stock Option (Right to Buy)derivative | +5,853 | $0.00 | $0 | 5,853 | Jun 10, 2026 |
| Mar 5, 2026 | PRCT PROCEPT BioRobotics Corp | AGrant or award Common Stock | +5,476 | $0.00 | $0 | 5,476 | Mar 9, 2026 |
| Mar 5, 2026 | PRCT PROCEPT BioRobotics Corp | AGrant or award Stock Option (Right to Buy)derivative | +8,897 | $0.00 | $0 | 8,897 | Mar 9, 2026 |
| Dec 8, 2023 | SWAV Shockwave Medical, Inc. | SOpen-market sale Common Stock10b5-1 | -200 | $173.88 | $35k | 28,784 | Dec 11, 2023 |
| Nov 2, 2023 | SWAV Shockwave Medical, Inc. | FTax withholding Common Stock | -204 | $214.07 | $44k | 28,984 | Nov 15, 2023 |
Questions about Dan Puckett
Answered from the filings on this page, as of the latest one.
Is Dan Puckett buying or selling?
Not in the last 12 months. Dan Puckett's latest open-market trade on SEC Form 4 was sold $35k of SWAV on Dec 8, 2023.
How did Dan Puckett's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dan Puckett has 0.
Where does Dan Puckett file Form 4?
Dan Puckett has filed Form 4 at SWAV (Shockwave Medical, Inc.) as Chief Financial Officer; PRCT (PROCEPT BioRobotics Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.